COMPASS Pathways plc Stock Price

NasdaqGS:CMPS Community·US$655.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
29 Fair Values set on narratives written by author

Create a narrative

CMPS Share Price Performance

US$6.52

0.13 (2.03%)

US$6.52

0.13 (2.03%)

US$6.52

Sat, 18 Oct 25

Share PriceUS$6.52

CMPS Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

0 Risks

0 Rewards

View Full Analysis

COMPASS Pathways plc Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -1.44
: 0%
: 0%
: 19.0%

View Full Analysis

About CMPS

Founded: 2020
Employees: 166
CEO: Kabir Nath
WebsiteView website: compasspathways.com

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.